Literature DB >> 27641667

miR-361-5p inhibits hepatocellular carcinoma cell proliferation and invasion by targeting VEGFA.

Wenxian Cui1, Yuanguo Li1, Keqing Xu1, Guijin Chen1, Xiaoqun Lu1, Qiuqin Duan1, Zhirong Kang1.   

Abstract

MicroRNAs (miRNAs) play important roles in the pathogenesis of many types of cancers by negatively regulating gene expression at posttranscriptional level. Here, we found that miR-361-5p is down-regulated in 135 patients with HCV-related hepatocellular carcinoma (HCC). Moreover, the expressions of miR-361-5p were highly correlated with VEGFA in these HCC patients. Further, CCK-8 proliferation assay indicated that miR-361-5p mimics inhibited the cell proliferation of HepG2 and SNU-398 HCC cells. Transwell assay showed that miR-361-5p mimics inhibited the invasion and migration of HepG2 and SNU-398 HCC cells. Luciferase assays revealed that miR-361-5p directly bound to the 3'untranslated region of VEGFA, and western blotting showed that miR-361-5p inhibited the expression of VEGFA. Generally, this study indicated that miR-361-5p is down-regulated in HCC and inhibits proliferation and invasion of HCC cell lines via VEGFA. In future, miR-361-5p will be a potential therapeutic agent for HCC.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Keywords:  HCV; Hepatocellular carcinoma; VEGFA; miR-361-5p

Mesh:

Substances:

Year:  2016        PMID: 27641667     DOI: 10.1016/j.bbrc.2016.09.076

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  MiR-361-5p inhibits glycolytic metabolism, proliferation and invasion of breast cancer by targeting FGFR1 and MMP-1.

Authors:  Fei Ma; Lei Zhang; Li Ma; Yiyun Zhang; Jianguo Zhang; Baoliang Guo
Journal:  J Exp Clin Cancer Res       Date:  2017-11-13

Review 2.  The Role of MicroRNAs in Hepatocellular Carcinoma.

Authors:  Xin Xu; Yuquan Tao; Liang Shan; Rui Chen; Hongyuan Jiang; Zijun Qian; Feng Cai; Lifang Ma; Yongchun Yu
Journal:  J Cancer       Date:  2018-09-08       Impact factor: 4.207

3.  Long noncoding RNA MIR31HG abrogates the availability of tumor suppressor microRNA-361 for the growth of osteosarcoma.

Authors:  Yongjie Sun; Xinghao Jia; Mingxing Wang; Yiqi Deng
Journal:  Cancer Manag Res       Date:  2019-08-30       Impact factor: 3.989

4.  Dysregulation of serum miR-361-5p serves as a biomarker to predict disease onset and short-term prognosis in acute coronary syndrome patients.

Authors:  Wenqing Zhang; Guannan Chang; Liya Cao; Gang Ding
Journal:  BMC Cardiovasc Disord       Date:  2021-02-05       Impact factor: 2.298

5.  miR-361-5p regulates ovarian cancer cell proliferation and apoptosis by targeting TRAF3.

Authors:  Jianmei Ling; Panwen He
Journal:  Exp Ther Med       Date:  2021-01-11       Impact factor: 2.447

6.  MicroRNA-361-5p Inhibits Tumorigenesis and the EMT of HCC by Targeting Twist1.

Authors:  Liang-Chun Yin; Gang Xiao; Rui Zhou; Xiao-Ping Huang; Ning-Lei Li; Can-Liang Tan; Feng-Jiao Xie; Jun Weng; Li-Xin Liu
Journal:  Biomed Res Int       Date:  2020-12-17       Impact factor: 3.411

7.  E2F1-Induced lncRNA BAIAP2-AS1 Overexpression Contributes to the Malignant Progression of Hepatocellular Carcinoma via miR-361-3p/SOX4 Axis.

Authors:  Yan Yang; Hong Ge; De-Qing Li; Ai-Xia Xu
Journal:  Dis Markers       Date:  2021-09-25       Impact factor: 3.434

8.  Downregulation of lncRNA SBF2-AS1 inhibits hepatocellular carcinoma proliferation and migration by regulating the miR-361-5p/TGF-β1 signaling pathway.

Authors:  Yan-Hui Wu; Bin Yu; Wei-Xun Chen; Xi Ai; Wei Zhang; Wei Dong; Ya-Jie Shao
Journal:  Aging (Albany NY)       Date:  2021-08-02       Impact factor: 5.682

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.